Inhaled nitric oxide therapy in acute bronchiolitis: A multicenter randomized clinical trial

[1]  Wang Ya-ting,et al.  Diagnosis,Management and Prevention of Bronchiolitis , 2008 .

[2]  V. Novack,et al.  Modified Tal Score: Validated score for prediction of bronchiolitis severity , 2018, Pediatric pulmonology.

[3]  R. Dagan,et al.  Nitric oxide inhalations in bronchiolitis: A pilot, randomized, double‐blinded, controlled trial , 2018, Pediatric pulmonology.

[4]  M. Lanari,et al.  Immune and inflammatory response in bronchiolitis due to respiratory Syncytial Virus and Rhinovirus infections in infants. , 2017, Paediatric respiratory reviews.

[5]  T. Boyce.  More on Viral Bronchiolitis in Children. , 2016, The New England journal of medicine.

[6]  Chris C. Miller,et al.  Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study , 2016, Infection.

[7]  S. Lewis,et al.  Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial , 2015, The Lancet.

[8]  C. Bogdan.  Nitric oxide synthase in innate and adaptive immunity: an update. , 2015, Trends in immunology.

[9]  Eneida A. Mendonça,et al.  Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis , 2014, Pediatrics.

[10]  Chris C. Miller,et al.  Inhaled nitric oxide decreases the bacterial load in a rat model of Pseudomonas aeruginosa pneumonia. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[11]  A. Schaefer,et al.  Prophylactic nitric oxide treatment reduces incidence of bovine respiratory disease complex in beef cattle arriving at a feedlot. , 2013, Research in veterinary science.

[12]  C. Camargo,et al.  Trends in Bronchiolitis Hospitalizations in the United States, 2000–2009 , 2013, Pediatrics.

[13]  Chris C. Miller,et al.  Gaseous nitric oxide reduces influenza infectivity in vitro , 2013, Nitric Oxide.

[14]  Chris C. Miller,et al.  A phase I clinical study of inhaled nitric oxide in healthy adults. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[15]  Tebeb Gebretsadik,et al.  The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. , 2009, The Journal of allergy and clinical immunology.

[16]  Chris C. Miller,et al.  Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure. , 2009, Nitric oxide : biology and chemistry.

[17]  T. Kaisho,et al.  Host-pathogen interactions. , 2008, Current opinion in immunology.

[18]  P. Tripathi.  Nitric oxide and immune response. , 2007, Indian journal of biochemistry & biophysics.

[19]  A. Ghahary,et al.  Potential application of gaseous nitric oxide as a topical antimicrobial agent. , 2006, Nitric oxide : biology and chemistry.

[20]  J. Klingström,et al.  Nitric Oxide Inhibits the Replication Cycle of Severe Acute Respiratory Syndrome Coronavirus , 2005, Journal of Virology.

[21]  P. Gustafsson,et al.  Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. , 2005, American journal of respiratory and critical care medicine.

[22]  Bing Sun,et al.  Inhalation of Nitric Oxide in the Treatment of Severe Acute Respiratory Syndrome: A Rescue Trial in Beijing , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  F. Fang.  Antimicrobial reactive oxygen and nitrogen species: concepts and controversies , 2004, Nature Reviews Microbiology.

[24]  C. Lowenstein,et al.  Peroxynitrite inhibition of Coxsackievirus infection by prevention of viral RNA entry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Osterhaus,et al.  Inhibition of influenza virus replication by nitric oxide. , 2001, Journal of virology.

[26]  C. Lowenstein,et al.  An Antiviral Mechanism of Nitric Oxide , 1999, Immunity.

[27]  F. Fang.  Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. , 1997, The Journal of clinical investigation.

[28]  J. D. Young,et al.  Kinetics of methaemoglobin and serum nitrogen oxide production during inhalation of nitric oxide in volunteers. , 1996, British journal of anaesthesia.

[29]  J. Stamler,et al.  Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation , 1994, Cell.

[30]  G. Karupiah,et al.  Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. , 1993, Science.

[31]  K. Croen,et al.  Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. , 1993, The Journal of clinical investigation.

[32]  H. Majima.  [Phase I clinical study]. , 1984, Gan to kagaku ryoho. Cancer & chemotherapy.

[33]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[34]  K. Johnson.  An Update. , 1984, Journal of food protection.